Xhale Asthma Study

About the Study:

This study is testing the safety and efficacy of an investigational treatment for asthma in comparison to already FDA approved QVAR® inhaler and placebo. The study medication being evaluated is a potential generic version of an already approved medication. If enrolled in the study, participants can expect to spend up to 6 weeks in the study, including an initial screening and baseline visit followed by scheduled clinic visits.

To pre-qualify for this study, you must:

  • Be between 18 and 70 years of age
  • Diagnosed with asthma for at least one year
  • Must be on a stable dose asthma treatment for the past four weeks

Qualified participants, will receive:

  • Study related medications
  • Office visits and examinations at no cost
  • Compensation for time and travel may be provided

Health insurance is not needed to participate.

call 512-345-8900 or email mystudy@scrtrials.com

Created By
Sirius Clinical Research

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a copyright violation, please follow the DMCA section in the Terms of Use.